Control of allergic rhinitis and asthma test – a formal approach to the development of a measuring tool

Abstract

Background: The concurrent management of allergic rhinitis and asthma (ARA) has been recommended by Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. However, a tool capable of assessing simultaneously the control of upper and lower airways diseases is lacking.

Evaluation of Allergic Rhinitis and Asthma Control in a Portuguese Community Pharmacy Setting

“…[18][19][20] The CARAT has been used in clinical practice but has not been studied in a community pharmacy setting. There are few studies that analyze the role of pharmacists for detecting level of ARA control.…”

Allergen-Specific Immunotherapy in Children. Standardizing the Efficacy Evaluation Approaches

“…Также разработан Индекс преимуществ пациента (Patient Benefit Index, PBI) [37], который состоит из 25 вопросов, на которые необходимо ответить дважды -до и после терапии. Опросники ретроспективно дают возможность оценить ответ на терапию у конкретного пациента; анкеты просты и быстры в использовании, валидированы, коррелируют с клиническим улучшением и с показателями качества жизни [36][37][38].…”

Health-Related Quality of Life and Rhinitis Control Measures in Allergic Rhinitis

“…Initially, a version consisting of 17 questions was developed to be used in the concurrent management of these diseases, as recommended by the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines [57]. This was then shortened to the CARAT10, consisting of ten questions that refer to the control of these diseases in the previous 4 weeks.…”